SenJam Blog

Get out there and think outside the box

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla.

england-shoes

Sen-Jam Pharmaceutical Takes the Stage at European Biopharma Obesity Innovation Forum

We could not be more proud of Jackie—our brilliant Female Founder and the only woman on today’s stage—and of our team’s...

The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at the Global Passion Project Summit

There are rare moments when political urgency, scientific progress, and cultural appetite collide — creating the...

Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transformative Healthcare Summit in Palm Beach

HUNTINGTON, N.Y., April 1, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is proud to sponsor and participate in The Global...

Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C

One year ago, we filed a provisional patent application for our Upper Respiratory Infection Therapeutic – SJP-002C,...

Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ashley St. John to its Scientific Advisory Board

HUNTINGTON, N.Y., March 11, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is thrilled to announce the appointment of Dr....

Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships for SJP-001 & SJP-002C

HUNTINGTON, N.Y., Feb. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a pioneering biotech company dedicated to...

Sen-Jam Pharmaceutical Announces Planned AI Initiative for Repurposed Drug Development

HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical (“Sen-Jam”), a pioneer in innovative inflammatory...

New Global Scientific Paper Published on Alcohol Hangover, Inflammation, and Health

Sen-Jam Pharmaceutical is proud to celebrate the recent publication of an insightful new paper by Dr. Joris C. Verster,...

Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approach to Address Obesity and Metabolic Disorders

HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care,...
CTA 1

Heading Module -CTA Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Lorem Ipsum

Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim. Aliquam lorem ante, dapibus in, viverra quis. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim. Aliquam lorem ante, dapibus in, viverra quis